Day: December 30, 2020

MONTREAL, Dec. 30, 2020 (GLOBE NEWSWIRE) — Intema Solutions Inc. (“Intema” or the “Corporation”) (TSXV: ITM, OTCMKTS: ITMZF) announces that it has granted a total of 2,600,000 stock options to Officers, Directors, Employees and Consultants pursuant to the Corporation’s stock option plan. The stock options have an exercise price of $0.2325 per share, will vest in four equal tranches and expire in 5 years.About Intema Solutions Inc.Intema has been simplifying and optimizing the online marketing activities of medium and large companies through innovative technologies and cutting-edge expertise for over 20 years. A Canadian leader in permission-based email marketing, Intema provides a wide range of products and services, including SMS, content and predictive AI marketing, as well as related professional services. For more information,...

MONTRÉAL, 30 déc. 2020 (GLOBE NEWSWIRE) — Intema Solutions Inc. (« Intema » ou la « Société ») (TSXV: ITM, OTCMKTS: ITMZF) annonce qu’elle a octroyé un total de 2 600 000 options d’achat d’actions aux dirigeants, administrateurs, employés et consultants dans le cadre du régime d’options d’achat d’actions de la Société. Les options d’achat d’actions ont un prix d’exercice de 0,2325 $ par action, seront acquises en quatre tranches égales et expireront dans 5 ans.À propos d’Intema Solutions Inc.La mission d’Intema est d’être la première plateforme de marketing numérique au monde. Depuis plus de 20 ans, la Société simplifie et optimise les activités de marketing en ligne des moyennes et grandes entreprises grâce à des technologies novatrices et à une expertise de pointe. Chef...

TORONTO and HOUSTON, Dec. 30, 2020 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (NASDAQ: MDNA, TSX: MDNA), a clinical stage immuno-oncology company, announced today that it has entered into a sales agreement with SVB Leerink acting as sales agent (the “Sales Agreement”), pursuant to which the Company may, from time to time sell, through “at-the-market” offerings on the Nasdaq Capital Market (the “Nasdaq”) such number of common shares as would have an aggregate offering price of up to US$25 million (the “ATM Offering”) under the ATM Prospectus Supplement (as defined below).SVB Leerink, at Medicenna’s discretion and instruction, will use its commercially reasonable efforts to sell the common shares at prevailing market prices from time to time. No offers or sales of common shares will be made in Canada...

VANCOUVER, British Columbia, Dec. 30, 2020 (GLOBE NEWSWIRE) — Eden Empire Inc. (CSE: EDEN) (the “Company” or “Eden”) is pleased to announce that its common shares will commence trading effective at the open of the Canadian Securities Exchange (“CSE”) on Monday, January 4, 2021 under the ticker symbol “EDEN”.Eden Empire, using its award winning and established nationwide brand will operate retail cannabis stores in Canada and the United States. The Company has the intention to expand its business to cannabis cultivation, extraction and processing‎ and become a fully integrated cannabis product company in various states throughout the US.Gerry Trapasso, Director & CEO, commented, “We have strategically positioned Eden to access a niche market in the cannabis sector. We look...

Common stock of the merged company, Clene Inc., to commence trading on the NASDAQ Capital Market under the ticker symbol “CLNN” on December 31, 2020Clinical pipeline includes an ongoing Phase 3 study in amyotrophic lateral sclerosis (ALS) and four concurrent Phase 2 studies in ALS, multiple sclerosis and Parkinson’s diseaseProceeds from the transaction totaled approximately $31.9 million, combining funds held in Tottenham’s trust account and a concurrent $22.4 million PIPE financingSALT LAKE CITY, Dec. 30, 2020 (GLOBE NEWSWIRE) — Clene Nanomedicine, Inc. (“Clene”) (NASDAQ: CLNN), a clinical-stage biopharmaceutical company, today announced the closing of a merger with Tottenham Acquisition I Limited (“Tottenham”) and provided a corporate update. Proceeds from this transaction totaled approximately $31.9 million, which included funds...

STRATHROY, Ontario, Dec. 30, 2020 (GLOBE NEWSWIRE) — Eve & Co. Incorporated (TSXV: EVE) (OTCQX: EEVVF) (the “Company” or “Eve & Co”) announces that its wholly-owned subsidiary Natural MedCo Ltd (“NMC”) has entered into a CAD$1M financing loan with a private consortium of lenders (the “CAD$1M financing” or the “Loan”).The CAD$1M financing has a two-year term and is to be received in two equal tranches of CAD$500,000. The first CAD$500,000 tranche has been received – net of issuance costs of approximately CAD$29,000 – and bears interest – payable monthly – at 15% per annum for the first year and 11% per annum for the second year. Monthly repayments of principal and interest can only be made during the second year of the term. The principal outstanding will be repaid to the Lender at the end of the two-year term.The second...

VANCOUVER, British Columbia, Dec. 30, 2020 (GLOBE NEWSWIRE) — Novo Resources Corp. (“Novo” or the “Company”) (TSX-V: NVO & NVO.WT; OTCQX: NSRPF) is pleased to announce that it has received final approval from Toronto Stock Exchange (“TSX”) to graduate from the TSX Venture Exchange (the “TSXV”) and list on TSX its common shares (the “Shares”) and all 8,596,184 common share purchase warrants (the “Warrants”) issued pursuant to the Company’s brokered and non-brokered private placements in August (please see the Company’s news release dated August 27, 2020 for further details).The Shares and Warrants will commence trading on TSX under their existing ticker symbols “NVO” and “NVO.WT”, respectively, at the market open on January 4, 2021. Accordingly, December 31 will be the last day of trading of the Company’s securities on the TSXV....

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, Dec. 30, 2020 (GLOBE NEWSWIRE) — Stone Gold Inc. (TSX-V: STG) (“Stone Gold” or the “Company“) is pleased to announce that it has completed a non-brokered private placement, previously announced on December 16, 2020, for aggregate gross proceeds of $500,000 (the “Offering”). The Offering consisted of the sale of 2,500,000 flow through units (the “FT Units”) at a price of $0.20 per FT Unit.Each FT Unit consists of one (1) common share of the Company issued on a flow-through basis within the meaning of the Income Tax Act (Canada) (a “FT Share”), and one-half of one (0.5) common share purchase warrant (each whole warrant, a “Warrant”), with each Warrant entitling the holder thereof to acquire one additional...

TORONTO, Dec. 30, 2020 (GLOBE NEWSWIRE) — RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM”) (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical and other cannabis-based products, is pleased to announce that the Company has acquired 49% of Canapar Corp. (“Canapar”) (the “Canapar Shares”). The Canapar Shares were acquired from Canopy Rivers Corporation (“Canopy Rivers”), a wholly owned subsidiary of Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF). Canapar, through its wholly owned subsidiary Canapar SrL (“Canapar Italy”), will be one of Europe’s largest vertically integrated Cannabis companies when fully operational. Canapar’s state of the art extraction plant is the largest in Europe and has been custom designed for the production of active compounds to be used in high-quality...

VANCOUVER, British Columbia, Dec. 30, 2020 (GLOBE NEWSWIRE) — Integra Resources Corp. (“Integra” or the “Company”) (TSX-V: ITR; NYSE American: ITRG) today announced that it has entered into an at-the-market Equity Distribution Agreement (the “Agreement”) with Stifel, Nicolaus & Company, Incorporated (“Stifel”) to establish an at-the-market equity program (the “ATM Program”). The ATM Program, if used, will allow Common Shares to be issued in an opportunistic manner from treasury to the public from time to time, at the Company’s discretion. If the Company decides to utilize the ATM Program, net proceeds would be expected to fund additional exploration drilling. Any Common Shares sold under the ATM Program will be sold at the prevailing market price at the time of sale, when sold through the NYSE American LLC (“NYSE American”)...